CLINICAL RESEARCH IN CANADA
A Roadmap for Enhancing Canada's Global Competitiveness
______________________________________________________________
Why are we in crisis?
What are the main causes and consequences?
What are some of the potential solutions?
The Canadian Institute brings together key industry leaders and stakeholders to discuss Canada’s place in the clinical research global landscape. This important event will give you the critical information you need to develop proactive strategies to build Canada’s competitive advantage.
This interactive program includes key policy makers from both the federal and provincial government who will share their vision and their plans to lead Canada through these challenging times. You will also hear the latest best practices and innovations that are coming down the pipeline from big pharma, biotech, CROs, research hospitals and universities.
Highlights include:
- Solutions implemented to transform R&D, accelerate drug development and reduce costs
- SWOT analysis panel on our Strengths, Weaknesses, Opportunities and Threats
- Regulatory update and future directions
- Principal investigator’s perspective on personalized medicine and the role of biomarkers in Canadian trials
- Roles and responsibilities with the newly proposed Canadian Council for Research Integrity
- Multi-centred trials and the impact on ethics review
- Overcoming potential risks in tracking Phase 1 trial participants
- Increasing efficiencies and improving ROI through an Adaptive Design
- How Social media can positively or negatively impact your clinical trials
- Top 10 do’s and don’ts for clinical research sites